Your browser doesn't support javascript.
loading
The role of allogeneic transplant for adult Ph+ ALL in CR1 with complete molecular remission: a retrospective analysis.
Ghobadi, Armin; Slade, Michael; Kantarjian, Hagop; Alvarenga, Julio; Aldoss, Ibrahim; Mohammed, Kahee A; Jabbour, Elias; Faramand, Rawan; Shah, Bijal; Locke, Frederick; Fingrut, Warren; Park, Jae H; Short, Nicholas J; Gao, Feng; Uy, Geoffrey L; Westervelt, Peter; DiPersio, John F; Champlin, Richard E; Al Malki, Monzr M; Ravandi, Farhad; Kebriaei, Partow.
  • Ghobadi A; Section of Stem Cell Transplant and Leukemia, Division of Oncology, Department of Medicine, Washington University School of Medicine, St. Louis, MO.
  • Slade M; Section of Stem Cell Transplant and Leukemia, Division of Oncology, Department of Medicine, Washington University School of Medicine, St. Louis, MO.
  • Kantarjian H; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX.
  • Alvarenga J; City of Hope National Medical Center, Duarte, CA.
  • Aldoss I; City of Hope National Medical Center, Duarte, CA.
  • Mohammed KA; Section of Stem Cell Transplant and Leukemia, Division of Oncology, Department of Medicine, Washington University School of Medicine, St. Louis, MO.
  • Jabbour E; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX.
  • Faramand R; Moffitt Cancer Center, University of South Florida, Tampa, FL.
  • Shah B; Moffitt Cancer Center, University of South Florida, Tampa, FL.
  • Locke F; Moffitt Cancer Center, University of South Florida, Tampa, FL.
  • Fingrut W; Memorial Sloan Kettering Cancer Center, New York, NY.
  • Park JH; Memorial Sloan Kettering Cancer Center, New York, NY.
  • Short NJ; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX.
  • Gao F; Section of Stem Cell Transplant and Leukemia, Division of Oncology, Department of Medicine, Washington University School of Medicine, St. Louis, MO.
  • Uy GL; Section of Stem Cell Transplant and Leukemia, Division of Oncology, Department of Medicine, Washington University School of Medicine, St. Louis, MO.
  • Westervelt P; Section of Stem Cell Transplant and Leukemia, Division of Oncology, Department of Medicine, Washington University School of Medicine, St. Louis, MO.
  • DiPersio JF; Section of Stem Cell Transplant and Leukemia, Division of Oncology, Department of Medicine, Washington University School of Medicine, St. Louis, MO.
  • Champlin RE; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson, Cancer Center, Houston, TX.
  • Al Malki MM; City of Hope National Medical Center, Duarte, CA.
  • Ravandi F; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX.
  • Kebriaei P; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson, Cancer Center, Houston, TX.
Blood ; 140(20): 2101-2112, 2022 11 17.
Article en En | MEDLINE | ID: mdl-35877996
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Trasplante de Células Madre Hematopoyéticas / Leucemia-Linfoma Linfoblástico de Células Precursoras Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Humans Idioma: En Año: 2022 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Trasplante de Células Madre Hematopoyéticas / Leucemia-Linfoma Linfoblástico de Células Precursoras Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Humans Idioma: En Año: 2022 Tipo del documento: Article